Designating September 15, 2021, as “International Myotonic Dystrophy Awareness Day” and supporting the goals and ideals of International Myotonic Dystrophy Awareness Day.

committing to promoting and advancing the health, well-being, and inherent dignity of all children and adults with myotonic dystrophy;

supporting the advancement of scientific and medical myotonic dystrophy research at the National Institutes of Health and as part of the Peer Reviewed Medical Research Program of the Department of Defense;

fostering biopharmaceutical innovation that will lead to treatments approved by the Food and Drug Administration and eventually a cure for myotonic dystrophy;

advancing programs and policies that assist individuals disabled by myotonic dystrophy and the caregivers of those individuals; and

encouraging awareness and education of myotonic dystrophy among patients, caregivers, clinicians, and researchers.